St. Jude takes No. 2 spot in ICD market

10/19/2006 | Twincities.com · TheStreet.com

Although its implantable cardioverter defibrillator sales declined by 2%, St. Jude Medical beat analysts' expectations when it posted $116 million in earnings. The company's CEO, Dan Starks, also announced that the company's third quarter was "the tipping point when St. Jude became the clear No. 2 in selling pacemakers and ICDs," overtaking Boston Scientific Corp.

View Full Article in:

Twincities.com · TheStreet.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR